Flagship Development Programme
Medi AI+ is Provenant AI Labs' flagship R&D programme for locally operated, human-governed clinical AI infrastructure. It is currently in pre-clinical engineering and controlled laboratory development, progressing from TRL 3 toward TRL 4.
Powered by PeachBot platform
Status
TRL 3 → TRL 4
Environment
Pre-clinical engineering and controlled laboratory development
Target environment
Hospitals, clinical research environments, and healthcare institutions, subject to validation and approval
Clinical Edge AI Prototype Programme
Powered by PeachBot platform
Provenant AI Labs' flagship R&D programme for locally operated, human-governed clinical AI infrastructure progressing from TRL 3 engineering proof-of-concept toward an integrated TRL 4 laboratory prototype.
Prototype Ecosystem Element
Planned prototype component · not a commercial product
Powered by PeachBot platform
A coordinated set of clinical input peripherals for pilot sites evaluating localized multimodal workflow documentation.
Future application pathways
These privacy-preserving healthcare AI pathways are research and development concepts, not currently available products. Definitions are preserved for future reactivation and qualified programme planning.
Future edge-AI imaging workflow pathway.
Future pathway · under development
Future laboratory workflow pathway.
Future pathway · under development
Future distributed-care pathway.
Future pathway · under development
Future perioperative workflow pathway.
Future pathway · under development
Pilot & Regulatory Notice
Medi AI+ is currently a pre-clinical engineering programme. Product concepts and pilot configurations shown on this website are for stakeholder evaluation, controlled pilot planning, and qualified commercial discussion only. They are not represented as HSA-registered or approved medical devices, diagnostic systems, treatment systems, autonomous clinical decision-making, or substitutes for professional clinical judgement. It is not approved for diagnosis, treatment, or unsupervised clinical use. Any Singapore deployment must undergo appropriate institutional review, clinical governance, cybersecurity assessment, procurement checks, PDPA/data protection review, and, where applicable, Health Sciences Authority (HSA) medical-device classification, registration, licensing, and approval processes before clinical or operational use.